Relay Therapeutics, Inc. (NASDAQ:RLAY) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eleven research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price […]
Shares of Relay Therapeutics, Inc. (NASDAQ:RLAY – Get Free Report) have earned a consensus rating of “Moderate Buy” from the eleven research firms that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and nine have given a buy recommendation to the company. The average twelve-month price […]
